[Interpretation and comparison of international guidelines for salivary gland malignancy in 2021].
Zhonghua Kou Qiang Yi Xue Za Zhi
; 57(2): 136-141, 2022 Feb 09.
Article
in Zh
| MEDLINE
| ID: mdl-35152648
ABSTRACT
In order to provide evidence-based recommendations on the management of salivary gland malignancy (SGM), the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) formulated and updated SGM clinical practice guidelines respectively in 2021.The two guidelines are interpreted and compared in this article from six perspectives including preoperative evaluations, surgical diagnostic and therapeutic procedures, appropriate radiotherapy techniques, the role of systemic therapy, follow-up evaluations and recurrent-metastatic diseases' management of SGM, which has guiding significance for diagnosis and treatment of SGM in China.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Salivary Gland Neoplasms
Type of study:
Diagnostic_studies
/
Guideline
Limits:
Humans
Country/Region as subject:
Asia
Language:
Zh
Journal:
Zhonghua Kou Qiang Yi Xue Za Zhi
Journal subject:
ODONTOLOGIA
Year:
2022
Document type:
Article
Affiliation country: